Epiminder Limited develops and markets the Minder system, an FDA-authorised implantable continuous EEG monitoring device designed for long-term brain activity tracking. The technology serves healthcare professionals and patients managing drug-resistant epilepsy by providing actionable seizure data and facilitating remote care.
Subscribe to see EPIMINDER LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EPIMINDER LIMITED is a health care equipment & services company headquartered in Australia. Xcout tracks 16 named people at EPIMINDER LIMITED, including Rohan Hoare (Chief Executive Officer).
10 more named people on record for EPIMINDER LIMITED, with roles, board committees and tenure — see the full roster →
A few of EPIMINDER LIMITED's closest competitors — see the full list of competitors and alternatives →
Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East. The company's product portfolio is primarily focused on solutions for sleep and neurological disorders. For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S. for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO). Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler. Other software offerings include HD Digital Video integration and various specialized applications. Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors. Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.
MJN Neuro is a Spanish medical-device company developing wearable technology to detect epileptic seizures, particularly nocturnal seizures. Its systems are intended to alert caregivers or family members through connected devices, supporting people with epilepsy and those who monitor them.
Sinocare manufactures and provides continuous glucose monitoring (CGM) systems and related mobile applications for diabetes management.
Ottai provides a continuous glucose monitoring system and companion app designed for 24/7 glucose tracking. The company serves individuals managing diabetes by offering wearable devices and AI-powered insights to help monitor glucose fluctuations and build healthier habits without the need for finger pricks.
Simergent, LLC develops the Archimedes automated peritoneal dialysis system, a home dialysis device designed to be affordable, easy to use, and accessible for patients with end-stage kidney disease. The device is FDA cleared for both clinic and home use, allowing patients to undergo treatment without requiring a caregiver.
Element Science, Inc. is a U.S. medical-device company developing wearable cardiac-monitoring and defibrillation technologies, including the Jewel Patch wearable cardioverter defibrillator. Its products are intended to serve patients at temporary risk of sudden cardiac death and the clinicians who manage their care.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.